re: Ann: Leighton reports Q3 2013 results and... Seller appears to be done now, can't see any heavy sell orders going thru, and price is recovering?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025